| Net Cash Provided by (Used in) Operating Activities |
-9.29K |
USD |
-9.72% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
9.29K |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-21.3K |
USD |
+30.4% |
Q4 2023 |
Q1 2024 |
| Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2.75M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
34.7K |
USD |
+17.5% |
Q3 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
34.7K |
USD |
+17.5% |
Q3 2024 |
FY 2024 |
| Depreciation |
2K |
USD |
0% |
Q4 2023 |
Q1 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
165K |
USD |
+17.5% |
Q3 2024 |
FY 2024 |
| Additional Paid in Capital |
75.5K |
USD |
0% |
Q2 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
FY 2024 |
| Interest Expense |
9.79K |
USD |
+67.7% |
Q2 2025 |
Q3 2025 |